(Q51368802)

4 April 2018

title

Strontium ranelate prevents bone loss in a rat model of localized muscle paralysis. (English)

1 reference

4 April 2018

author name string

Zhi-Feng Sheng

1

1 reference

4 April 2018

Yu-Lin Ma

2

1 reference

4 April 2018

Dejun Tong

3

1 reference

4 April 2018

De-Yu Fang

4

1 reference

4 April 2018

Qing-Chun Liang

5

1 reference

4 April 2018

Li-Hong Liu

6

1 reference

4 April 2018

Jian Zhang

7

1 reference

4 April 2018

Er-Yuan Liao

8

1 reference

4 April 2018

publication date

12 January 2012

1 reference

4 April 2018

Annals of Biomedical Engineering

published in

1 reference

4 April 2018

volume

40

1 reference

4 April 2018

issue

3

1 reference

4 April 2018

page(s)

657-665

1 reference

4 April 2018

Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Disuse and orchidectomy have additional effects on bone loss in the aged male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Incorporation and distribution of strontium in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Glucocorticoid attenuates the anabolic effects of parathyroid hormone on fracture repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Longitudinal changes in femur bone mineral density after spinal cord injury: effects of slice placement and peel method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Physical activity in middle-aged women and hip fracture risk: the UFO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Disorders associated with acute rapid and severe bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Rebalancing bone turnover in favour of formation with strontium ranelate: implications for bone strength.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Strontium ranelate does not stimulate bone formation in ovariectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

S12911-2 reduces bone loss induced by short-term immobilization in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Role of carbonic anhydrase in bone: partial inhibition of disuse atrophy of bone by parenteral acetazolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Strontium ranelate: a physiological approach for optimizing bone formation and resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Compromised bone strength index in the hemiparetic distal tibia epiphysis among chronic stroke patients: the association with cardiovascular function, muscle atrophy, mobility, and spasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Increased serum osteocalcin levels in patients with paraplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Effects of immobilization on fetal bone development. A morphometric study in newborns with congenital neuromuscular diseases with intrauterine onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

The influence of center of rotation on the assessment of trabecular bone densitometric and structural properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Basic biomechanical measurements of bone: a tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Calcitonin treatment of immobilization osteoporosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Botox induced muscle paralysis rapidly degrades bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

Prevention of bone loss in paraplegics over 2 years with alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10439-011-0406-2

10.1007/S10439-011-0406-2

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018